Hyperfine, Inc. (Nasdaq: HYPR), a leader in health technology, showcased data at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago, highlighting the growing use of AI-powered portable MR brain imaging. Eleven prominent institutions presented clinical studies…
LivaNova PLC (Nasdaq: LIVN), a leading medical technology company, announced its participation in the American Epilepsy Society (AES) 2024 Annual Meeting, held December 6-10 in Los Angeles. The company will showcase its therapies and technologies for drug-resistant epilepsy through several…
GeneDx (Nasdaq: WGS), a leader in improving health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines (Nasdaq: PRAX), and Stoke Therapeutics (Nasdaq: STOK) as the founding partners of its Patient Access Program for pediatric epilepsy, offering…
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive tests for early-stage cancer detection, will join Federal Supply System (FSS) officials today in a joint presentation. The event will highlight the Veterans Health Administration (VHA) award that…
ICON plc (NASDAQ: ICLR), a global leader in clinical research powered by healthcare intelligence, today revealed the results of a recent global survey involving 101 biotech and pharma professionals from Europe and North America. The survey aimed to assess the…
Foundation Medicine, Inc. has announced the awarding of two grants to organizations focused on reducing disparities in biomarker testing for breast and prostate cancer. These grants follow an open call for proposals in April 2024, where Foundation Medicine sought collaborations…
Hippocratic AI, the company developing the first safety-focused Large Language Model (LLM) for healthcare, has announced a strategic partnership with the Nurses on Boards Coalition (NOBC) to empower nurses in healthcare technology. This partnership reflects Hippocratic AI’s commitment to fostering…
Novocure (NASDAQ: NVCR) announced that its pivotal Phase 3 PANOVA-3 trial successfully met its primary endpoint, showing a statistically significant improvement in median overall survival (mOS) compared to the control arm. The trial assessed the combination of Tumor Treating Fields…
Agiliti, a leading provider of medical device solutions, has announced the launch of its new Adapt Line™ of therapeutic hospital support surfaces. These surfaces are clinically designed to improve patient comfort and reduce the risk of pressure injuries caused by…
Flatiron Health today announced its participation in the upcoming San Antonio Breast Cancer Symposium (SABCS), with four accepted abstracts for poster presentation. Additionally, the company will sponsor a session titled “How Holistic Real-World Evidence Generation Advances Breast Cancer Research.” “We…
Almirall, a global pharmaceutical company focused on medical dermatology, today unveiled “The Hive,” a groundbreaking scientific research hub located at its R&D center in Barcelona, Spain. The Hive is designed to promote collaboration among researchers from biotech companies, start-ups, academia,…
Carlsmed, Inc., a MedTech company specializing in AI-driven personalized spine surgery, today announced that it has received FDA 510(k) clearance for the aprevo® Cervical ACDF Interbody System. This achievement highlights Carlsmed’s dedication to advancing patient-specific spine surgery solutions aimed at…